Jackson Health System Hematology and Medical Oncology

Topics

• Acute Myeloid Leukemia Research 411
• Lymphoma Diagnosis and Treatment 319
• Bladder and Urothelial Cancer Treatments 91
• Prostate Cancer Diagnosis and Treatment 73
• CAR-T cell therapy research 68
• Chronic Lymphocytic Leukemia Research 66
• Multiple Myeloma Research and Treatments 56
• Cancer Immunotherapy and Biomarkers 50
• Lung Cancer Treatments and Mutations 49
• Pancreatic and Hepatic Oncology Research 49
• T-cell and Retrovirus Studies 49
• Renal cell carcinoma treatment 39

Most cited

1. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.

   The New England journal of medicine · 2024 · 451 citations · James Hoffman

2. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 571 citations · Christos Kyriakopoulos

3. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.

   The Lancet. Oncology · 2022 · 573 citations · Joseph Rosenblatt

4. Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial.

   Lancet (London, England) · 2023 · 364 citations · Mikkael Sekeres

5. TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 468 citations · Christos Kyriakopoulos

6. Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.

   The New England journal of medicine · 2024 · 205 citations ·